Core Group
The Core Group (CG) provides leadership and sets the strategic direction for the programs of the WGND. It facilitates and accelerates decision-making and acts as a catalyst for effective implementation of programs and initiatives developed by the membership.
The CG is composed of the WGND Co-Chairs, the Leaders of the WGND Subgroups and a WGND Community Representative. The WGND Secretariat works with the CG to implement the strategic direction and initiatives of the WGND, develop action items and manage and administer WGND programs and the membership.
![](https://www.newtbdrugs.org/sites/default/files/styles/core_group/public/coregroup/Zaid_Tanvir%20%28002%29.jpg?itok=cVOIqwKz)
Zaid Tanvir
Secretariat
Global Alliance for TB Drug Development
New York, NY
![](https://www.newtbdrugs.org/sites/default/files/styles/core_group/public/coregroup/vandevelde.jpg?itok=qd6OqnLv)
Wim Vandevelde
Community Representative
Global TB Community Advisory Board
Capetown, South Africa
![](https://www.newtbdrugs.org/sites/default/files/styles/core_group/public/coregroup/Albert%20Makone%20%281%29.jpg?itok=jIM4oh3h)
Albert Makone
Community Representative
Harare, Zimbabwe
![](https://www.newtbdrugs.org/sites/default/files/styles/core_group/public/coregroup/lienhardt.jpg?itok=RJQu-Jwa)
Christian Lienhardt, MD, PhD
Critical Trial Capacity Subgroup Leader
Stop TB Partnership Secretariat World Health Organization
Geneva, Switzerland
![](https://www.newtbdrugs.org/sites/default/files/styles/core_group/public/coregroup/gumbo.jpg?itok=KVNB4H5Z)
Tawanda Gumbo
Critical Knowledge & Tools Subgroup Leader
UT Southwestern Medical Center
Dallas, TX, USA
![](https://www.newtbdrugs.org/sites/default/files/styles/core_group/public/coregroup/karakousis.jpg?itok=7Ck5Ce25)
Petros C. Karakousis, MD
Biology Targets Subgroup Leader
Center for TB Research, Johns Hopkins University
Baltimore, MD, USA
![](https://www.newtbdrugs.org/sites/default/files/styles/core_group/public/coregroup/TDick%202019.jpg?itok=t-3LRb1T)
Thomas Dick
Center for Discovery and Innovation, Hackensack Meridian Health
Nutley, NJ, USA
![](https://www.newtbdrugs.org/sites/default/files/styles/core_group/public/coregroup/spigelman.jpg?itok=Ue8eMyIg)
Mel Spigelman, MD
Co-Chair
Global Alliance for TB Drug Development
New York, NY, USA
![](https://www.newtbdrugs.org/sites/default/files/styles/core_group/public/coregroup/laughon.jpg?itok=i14XKyDK)
Barbara Laughon, PhD
Co-Chair & Candidates Subgroup Leader
Bethesda, MD, USA
New Members
The Working Group pipeline is open to anyone who is developing a TB drug. If you would like to become a member, please submit an application.
Apply NowQuestions? Contact Us